Richter-Helm Biologics and INOVIO will expand existing DNA manufacturing agreement to support large-scale manufacturing of Inovio’s investigational DNA vaccine for COVID-19

Richter-Helm Biologics, Gedeon Richter Plc. (“Richter”) and Helm AG’s joint venture microbial biotechnology contract development and cGMP manufacturing organization, today announced it has entered into an agreement with US based INOVIO (NASDAQ: INO) to expand its manufacturing partnership in order to support large-scale manufacturing of INOVIO’s investigational DNA vaccine for COVID-19, INO-4800, which is currently […]